INGR

WESTCHESTER, Ill., July 14, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its second quarter 2026 financial results for the period ended June 30, 2026, before the market opens Tuesday, August 4, 2026. Jim Zallie, chairman, president and chief executive officer and Jason Payant, vice president and interim chief financial officer, will host a conference call August 4 at 8 a.m. CT to discuss the Company's financial performance. The conference call and accompanying slide presentation will be webcast live at https://ir.ingredionincorporated.com/events-and-presentations. Participants are encouraged to log on to the webcast approximately 10 minutes before the start of the presentation. A replay of the presentation will be available on the Company's website. ABOUT INGREDIONIngredion Incorporated (NYSE: INGR), headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in more than 120 countries. With 2025 annual net sales of approximately $7.2 billion, the Company turns grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. With Ingredion’s Idea Labs® innovation centers around the world and more than 11,000 employees, the Company co-creates with customers and fulfills its purpose of bringing the potential of people, nature and technology together to make life better. Visit ingredion.com for more information and the latest Company news.

Over the past six months, Ingredion’s stock price fell to $96.75. Shareholders have lost 12.9% of their capital, which is disappointing considering the S&P 500 has climbed by 7.8%. This was partly driven by its softer quarterly results and might have investors contemplating their next move. Is now the time to buy Ingredion, or should you be careful about including it in your portfolio? Get the full breakdown from our expert analysts, it’s free. Despite the more favorable entry price, we’re cautious about Ingredion. Here are three reasons why there are better opportunities than INGR, plus one stock we’d rather own. Reviewing a company’s long-term sales performance reveals insights into its quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Over the last three years, Ingredion’s demand was weak and its revenue declined by 4.2% per year. This was below our standards and signals it’s a lower quality business. Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite. Over the next 12 months, sell-side analysts expect Ingredion’s revenue to rise by 1.7%. While this projection implies its newer products will catalyze better top-line performance, it is still below the sector average. If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills. As you can see below, Ingredion’s margin dropped by 7.1 percentage points over the last year. If its declines continue, it could signal increasing investment needs and capital intensity. Ingredion’s free cash flow margin for the trailing 12 months was 6.2%. Ingredion isn’t a terrible business, but it isn’t one of our picks. Following the recent decline, the stock trades at 8.6× forward P/E (or $96.75 per share). While this valuation is optically cheap, the potential downside is big given its shaky fundamentals. We’re fairly confident there are better investments elsewhere. We’d suggest looking at one of our top digital advertising picks. ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. If you are looking at Ingredion and wondering whether the current share price reflects its true worth, this article walks through the numbers behind the stock so you can judge the value for yourself. Ingredion last closed at US$99.66, with the share price down 2.1% over the past week, 7.2% over the past month, 9.2% year to date and 25.9% over the past year, while the three and five year returns sit at 0.8% and 21.5% respectively. Recent coverage around Ingredion has focused on how the stock has underperformed the broader Food industry over the last year and what that might say about market expectations, alongside attention on how its fundamentals compare with packaged food peers. This context matters because it can shape whether investors see the recent share price weakness as a potential opportunity or as a sign of higher perceived risk. On Simply Wall St's valuation checks, Ingredion scores a 6 out of 6, and the rest of this article will break down how different valuation approaches line up, before finishing with a more holistic way to think about the stock's value. Find out why Ingredion's -25.9% return over the last year is lagging behind its peers. A Discounted Cash Flow model takes estimates of the cash a company could generate in the future and discounts those back to today to arrive at an intrinsic value per share. It is essentially asking what those future streams of cash are worth in present dollars. For Ingredion, the model uses a 2 Stage Free Cash Flow to Equity approach, based on cash flows reported and projected in $. The latest twelve month free cash flow is about $554.6 million. Analysts provide detailed projections for the next few years, and Simply Wall St then extrapolates further out, including a projected free cash flow of $602.9 million in 2035. When all these projected cash flows are discounted back and combined, the model arrives at an estimated intrinsic value of about $197.82 per share. Compared with the recent share price of $99.66, this implies the stock trades at roughly a 49.6% discount to the DCF estimate. On this model, the shares appear undervalued. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests Ingredion is undervalued by 49.6%. Track this in your watchlist or portf...

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Ingredion’s refreshed analyst narrative is coming into focus as some bearish firms trim price targets by US$8, US$4, and US$2, while a bullish camp continues to point to a US$130 target. Those cuts reflect concerns about recent site specific headwinds and the pace of any earnings recovery, whereas more optimistic analysts highlight the company’s exposure to health, wellness, and affordability trends as support for their targets. Read on to see how these differing views fit together and how you can track the story as it develops. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page. Benchmark initiated coverage with a US$130 price target, arguing that Ingredion sits at the intersection of health, wellness, and affordability themes that could support its long term earnings profile. Benchmark highlights the stock for value and income oriented investors, pointing to what it views as a compelling entry point after site specific issues affected FY25 earnings. Barclays reduced its Ingredion price target by US$8, signaling a more cautious stance on execution and the timeline for any earnings recovery. Oppenheimer cut its target by US$4 and UBS trimmed by US$2, reflecting concern about site specific headwinds and the pace at which those issues might be resolved. Together, the target cuts suggest some analysts see near term risk around earnings visibility, even as others focus on longer term exposure to consumer trends. Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives! See how Ingredion's fair value stacks up across multiple valuation models — not just analyst targets. Ingredion agreed to acquire a 9% stake in India based Sanstar Limited and form a joint venture that plans a new western India facility to produce specialty pharmaceutical excipients and high value ingredient solutions for food and pharma markets. The Sanstar partnership is structured to combine Sanstar's local operating experience with Ingredion's gl...

WESTCHESTER, Ill., May 20, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions, announced today that its board of directors declared a quarterly dividend of $0.82 per share on the Company’s common stock. The quarterly dividend will be payable on July 21, 2026, to stockholders of record at the close of business on July 1, 2026. For more information about Ingredion Incorporated, including investor relations, financial updates and upcoming announcements, visit ir.ingredionincorporated.com. About Ingredion Ingredion Incorporated (NYSE: INGR), headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in more than 120 countries. With 2025 annual net sales of approximately $7.2 billion, the Company turns grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. With Ingredion’s Idea Labs® innovation centers around the world and more than 11,000 employees, the Company co-creates with customers and fulfills its purpose of bringing the potential of people, nature and technology together to make life better. Visit ingredion.com for more information and the latest Company news.

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the ingredients, flavors & fragrances industry, including Ingredion (NYSE:INGR) and its peers. Ingredients, flavors, and fragrances companies supply essential components to food, beverage, personal care, and household product manufacturers. These firms develop proprietary formulations that enhance taste, scent, and texture, creating customer stickiness through specialized expertise and regulatory-approved ingredient portfolios. Tailwinds include growing consumer demand for natural and clean-label products, expansion in emerging markets, and innovation in plant-based and functional ingredients. However, headwinds persist from volatile raw material costs, particularly for agricultural and petrochemical inputs. Regulatory scrutiny over synthetic additives and fragrance allergens poses compliance challenges, while consolidation among major customers increases pricing pressure and negotiating leverage against suppliers. The 5 ingredients, flavors & fragrances stocks we track reported a mixed Q1. As a group, revenues were in line with analysts’ consensus estimates. In light of this news, share prices of the companies have held steady. On average, they are relatively unchanged since the latest earnings results. Known for its ability to turn ordinary corn into thousands of different food ingredients, Ingredion (NYSE:INGR) transforms grains, fruits, vegetables and other plant-based materials into specialty starches, sweeteners and other ingredients for food, beverage and industrial markets. Ingredion reported revenues of $1.79 billion, down 1.2% year on year. This print was in line with analysts’ expectations, but overall, it was a softer quarter for the company with a significant miss of analysts’ EBITDA and gross margin estimates. “While we expected a challenging first quarter after last year’s strong first quarter, results were weaker than anticipated in Food & Industrial Ingredients—U.S./CAN due to operational challenges at our Argo facility,” said Jim Zallie, chairman, president and CEO of Ingredion. The stock is down 4% since reporting and currently trades at $102.62. Read our full report on Ingredion here, it’s free. With origins dating back to 1818 and operations spanning both hemispheres to balance seasonal harvests, Bunge Global (NYSE:BG) is an agribusiness and food...

Download the Complete Report Here Key Takeaways: Revenue growth remained positive in 1Q26, though the quarter primarily reflected continued early-scale execution rather than a step-function inflection. BOIL reported revenue of $1.26 million in 1Q26, up 24% y/y from $1.01 million and modestly above $1.24 million in 4Q25, implying an annualized run-rate of ~$5.0 million. The sequential increase of ~1% was limited, but the y/y growth confirms that commercial revenue is sustaining at a materially higher level than the prior-year base. The revenue increase reflected distributor revenue, additional revenue-generating agreements, and increased marketing efforts intended to expand global exposure, suggesting BOIL remains in the early phase of converting channel and customer development into recurring product demand. Strategic direction is now more clearly centered on revenue execution, customer rollout, and direct account-based selling. BOIL’s May strategic update reframes the next phase of commercialization around large strategic end customers, typically multi-location operators where the product can be deployed across dozens, hundreds, or thousands of sites. Target verticals include QSR, casual dining, other chain restaurants, hotels and hospitality groups, catering and institutional foodservice, supermarkets, and convenience-store operators. We believe this is a meaningful shift because it moves the commercial focus toward account-level penetration, operational integration, and repeat usage across high-value customers, while retaining targeted distribution support. The new U.S. fast-food chain rollout adds another important validation point for the direct-sales strategy. BOIL commenced commercial sales with a medium-sized American fast-food chain after a pilot validation program that began in late 2025 and expanded into a multi-location pilot in 1Q26. Initial commercial deployment has started with three franchisees across three U.S. states, while the broader chain has hundreds of locations across the U.S. and international markets. Although still early, the structure is attractive because it shows a clear progression from pilot validation to paid commercial sales, which is the key conversion point for BOIL’s refined go-to-market strategy. The announcement also came shortly after BOIL outlined its shift toward direct engagement with large multi-location operators,...

Ingredion’s first quarter was marked by operational setbacks and margin pressures, leading to a negative market reaction. Management pointed to significant challenges at the Argo production facility, which caused higher-than-expected costs and supply disruptions in the Food and Industrial Ingredients U.S./Canada segment. CEO Jim Zallie described the quarter as “weaker than anticipated,” emphasizing that additional operational problems at Argo resulted in $40 million of unexpected costs. Meanwhile, the Texture and Healthful Solutions segment delivered volume growth, but ongoing softness in Latin American demand and unfavorable currency movements further weighed on results. Is now the time to buy INGR? Find out in our full research report (it’s free). Revenue: $1.79 billion vs analyst estimates of $1.79 billion (1.2% year-on-year decline, in line) Adjusted EPS: $2.34 vs analyst expectations of $2.47 (5.3% miss) Adjusted EBITDA: $267 million vs analyst estimates of $285 million (14.9% margin, 6.3% miss) Management lowered its full-year Adjusted EPS guidance to $10.80 at the midpoint, a 5.3% decrease Operating Margin: 11.3%, down from 15.2% in the same quarter last year Constant Currency Revenue was down 3% year on year Market Capitalization: $6.70 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Jack Harden (Stephens) inquired whether U.S./Canada could regain mid-teens operating margins after Argo issues. CEO Jim Zallie confirmed the target for 2027, contingent on sustained operational reliability. Joshua Spector (UBS) asked how Ingredion expects to improve organic growth in Texture and Healthful Solutions as FX tailwinds lessen. Zallie cited investments in customer co-development and technical expertise to accelerate solution delivery. Benjamin Thomas Mayhew (BMO Capital Markets) questioned management’s ability to pass on rising energy costs and its effect on volumes. CFO Jason Payant explained that most direct costs can be passed through, but indirect demand impacts are harder to predict. Barclays Analyst sought clarification on why LatAm volumes lagged peers and whether mix or pricing was the primary headwind...

Image source: The Motley Fool. Tuesday, May 5, 2026 at 9 a.m. ET Chairman, President, and Chief Executive Officer — Jim Zallie Vice President, Investor Relations — Noah Weiss Vice President and Interim Chief Financial Officer Noah Weiss: Good morning, and welcome to Ingredion Incorporated’s first quarter 2026 earnings call. I am Noah Weiss, Vice President of Investor Relations. Joining me on today's call are Jim Zallie, our Chairman, President, and CEO, and our Vice President and interim CFO. The press release we issued today, as well as the presentation we will reference for our first quarter results, can be found on our website, ingredion.com, in the investors section. As a reminder, our comments within the presentation may contain forward-looking statements. These statements are subject to various risks and uncertainties and include expectations and assumptions regarding the company's future operations and financial performance. Actual results could differ materially from those estimated in the forward-looking statements, and Ingredion Incorporated assumes no obligation to update them in the future as or if circumstances change. Additional information concerning factors that could cause actual results to differ materially from those discussed during today's conference call or in this morning's press release can be found in the company's most recently filed annual report on Form 10-K and subsequent reports on Forms 10-Q and 8-K. During this call, we also refer to certain non-GAAP financial measures, including adjusted earnings per share, adjusted operating income, and adjusted effective tax rate, which are reconciled to U.S. GAAP measures in Note 2, Non-GAAP Information, included in the press release and in today's presentation appendix. With that, I will turn the call over to Jim. Jim Zallie: Thank you, Noah, and good morning, everyone. While we expected a challenging quarter after last year's strong first quarter, results were weaker than anticipated in Food and Industrial Ingredients U.S./Canada due to operational challenges at our Argo facility. At the same time, performance in our Texture and Healthful Solutions and Food and Industrial Ingredients LatAm segments were in line with our expectations despite an increasingly uncertain macroeconomic environment. Overall, net sales were down 1% and adjusted operating income was down 22% versus last year, dri...

A $40 million negative impact in Q1 was driven by unexpected operational failures at the Argo facility, specifically in corn conveying and syrup refining, which led to higher maintenance and rework costs. The Texture and Healthful Solutions segment achieved its eighth consecutive quarter of volume growth, signaling resilient demand for clean-label and functional ingredients despite broader macro uncertainty. Management is accelerating the 'brief-to-solution' cycle by leveraging artificial intelligence for predictive formulation and consumer insights within the $1 billion solutions portfolio. Strategic network optimization in Brazil included closing the Cabo facility to sharpen customer mix and consolidate production at more efficient flagship sites. Pea protein isolate sales grew over 50% in the quarter, reflecting successful innovation and strong consumer pull for protein-fortified and lower-sugar offerings. Full-year 2026 adjusted EPS guidance is revised to $10.45–$11.15, accounting for the Argo recovery timeline and transactional FX headwinds in Mexico. The outlook assumes sequential operational improvements at Argo, with downstream production already returned to normal levels and germ processing expected to recover within Q2. Management is implementing targeted price increases to offset rising logistics and packaging costs driven by higher energy prices in the Middle East. Guidance assumes the Mexican peso remains strong, presenting a transactional headwind as SG&A and operating costs are peso-denominated while sales are in USD. The company remains committed to returning to mid-to-high teens operating margins in the Food and Industrial Ingredients U.S./Canada segment by 2027. An isolated thermal event occurred at the Argo corn germ processing unit on April 10; the impact of this event will be excluded from adjusted results due to its non-recurring nature. The closure of the Cabo manufacturing facility in Brazil is expected to be completed by the end of Q2 2026 to drive enterprise productivity. Higher energy prices pose a risk to second-half consumer demand if inflationary pressures on packaging and gasoline impact lower-to-mid income household spending. A rapid rise in tapioca costs in Asia Pacific created a temporary margin lag in the Texture and Healthful Solutions segment during Q1. Our analysts just identified a stock with the potential to be the nex...

WESTCHESTER, Ill. (AP) — WESTCHESTER, Ill. (AP) — Ingredion Inc. (INGR) on Tuesday reported earnings of $142 million in its first quarter. On a per-share basis, the Westchester, Illinois-based company said it had net income of $2.22. Earnings, adjusted for one-time gains and costs, were $2.34 per share. The food sweetener, starch and nutritional ingredient company posted revenue of $1.79 billion in the period. Ingredion expects full-year earnings in the range of $10.45 to $11.15 per share. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INGR at https://www.zacks.com/ap/INGR

First quarter 2026 reported and adjusted* operating income decreased 26% and 22% compared to the first quarter 2025 First quarter 2026 reported and adjusted EPS were $2.22 and $2.34, compared with $3.00 and $2.97 in the first quarter 2025 Adjusting full-year guidance for reported EPS to be in the range of $9.60 to $10.30 and adjusted EPS to be in the range of $10.45 to $11.15 WESTCHESTER, Ill., May 05, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its first quarter 2026 results. “While we expected a challenging first quarter after last year’s strong first quarter, results were weaker than anticipated in Food & Industrial Ingredients—U.S./CAN due to operational challenges at our Argo facility,” said Jim Zallie, chairman, president and CEO of Ingredion. “At the same time, performance in our Texture & Healthful Solutions and Food & Industrial Ingredients—LATAM segments were in line with our expectations despite an increasingly uncertain macroeconomic environment.” “Texture & Healthful Solutions delivered an eighth consecutive quarter of broad-based net sales volume growth, driven by continued strong customer demand for our solutions portfolio, including clean label ingredients.” “Food & Industrial Ingredients—LATAM delivered as expected, reflecting disciplined execution across the region, while absorbing the year-over-year impact of Mexican foreign exchange headwinds.” * Reported results are in accordance with U.S. generally accepted accounting principles “GAAP.” Adjusted financial measures are non-GAAP financial measures. See “II. Non-GAAP Information” in the Supplemental Financial Information that follows the Condensed Consolidated Financial Statements for a reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures. “In our Food & Industrial Ingredients—U.S./CAN business, while we anticipated softer customer demand, a longer-than-expected recovery at our Argo facility negatively impacted results during the quarter. We remain focused on strengthening operational reliability, and we expect performance to improve sequentially throughout the second quarter; we are targeting a return to normal operations in the second half of the year." “Excluding the impact of Argo, we are pleased with the performance...